Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study (NuPOWER)

NCT05935358 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT05935358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05935358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study (NuPOWER)
Lead sponsor
Octapharma
Phase
Phase 4
Overall status
Recruiting
Start date
November 28, 2023
Completion date
September 30, 2026
Enrollment
28 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

severe hemophilia a